These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729 [TBL] [Abstract][Full Text] [Related]
30. Pap smears in women with endometrial carcinoma. Gu M; Shi W; Barakat RR; Thaler HT; Saigo PE Acta Cytol; 2001; 45(4):555-60. PubMed ID: 11480718 [TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma. Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767 [TBL] [Abstract][Full Text] [Related]
32. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888 [TBL] [Abstract][Full Text] [Related]
33. Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis. Stewart CJ; Doherty DA; Havlat M; Koay MH; Leung YC; Naran A; O'Brien D; Ruba S; Salfinger S; Tan J Pathology; 2013 Jun; 45(4):382-7. PubMed ID: 23635815 [TBL] [Abstract][Full Text] [Related]
34. Endometrial adenocarcinoma: beliefs and scepticism. Sivridis E; Giatromanolaki A Int J Surg Pathol; 2004 Apr; 12(2):99-105. PubMed ID: 15173914 [TBL] [Abstract][Full Text] [Related]
35. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin. Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724 [TBL] [Abstract][Full Text] [Related]
36. A report of two cases of dedifferentiated endometrioid carcinoma: A newly described underrecognized tumor of poor prognosis. Boler AK; Akhtar S; Bandyopadhyay A; Roy S Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S91-S93. PubMed ID: 32108637 [TBL] [Abstract][Full Text] [Related]
37. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues. Brustmann H; Naudé S Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718 [TBL] [Abstract][Full Text] [Related]
38. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Carcangiu ML; Chambers JT Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741 [TBL] [Abstract][Full Text] [Related]
40. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]